OMEROS CORP Public Float
OMEROS CORP (OMER) had Public Float of $172.38 million as of 2025-06-30, per its 10-K filed 2026-03-31.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-31
- 2025-06-30: Entity Public Float $172.38M.
- 2024-06-30: Entity Public Float $224.79M.
- 2023-06-30: Entity Public Float $328.15M.
- 2022-06-30: Entity Public Float $165.59M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $172.38M 10-K · filed 2026-03-31 |
| 2024-06-30 | $224.79M 10-K/A · filed 2025-04-30 |
| 2023-06-30 | $328.15M 10-K · filed 2024-04-01 |
| 2022-06-30 | $165.59M 10-K/A · filed 2023-05-01 |
| 2021-06-30 | $886.63M 10-K · filed 2022-03-01 |
| 2020-06-30 | $762.31M 10-K · filed 2021-03-01 |
| 2019-06-30 | $729.30M 10-K · filed 2020-03-02 |
| 2018-06-30 | $827.17M 10-K · filed 2019-03-01 |
| 2017-06-30 | $830.50M 10-K · filed 2018-03-01 |
| 2016-06-30 | $386.37M 10-K · filed 2017-03-16 |
| 2015-06-30 | $629.48M 10-K · filed 2016-03-15 |
| 2014-06-30 | $550.71M 10-K · filed 2015-03-16 |
| 2013-06-30 | $138.77M 10-K · filed 2014-03-13 |
| 2012-06-30 | $202.57M 10-K · filed 2013-03-18 |
| 2011-06-30 | $80.39M 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Innoviva, Inc. (INVA) | United States | $1.493B | 4.62 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |